James Faulkner interviews Chris Darbyshire, Chief Investment Officer at Seven Investment Management. James Faulkner: Hi Chris. Thanks for taking the time to speak with Master Investor today. Could you kick off by giving our readers a brief summary of 7IM and its offering to clients, as well as an overview of your role at the…
Building a wall? A ban on Muslims entering the US? Mass deportation of illegal immigrants? Anyone assessing some of Donald Trump’s more outlandish policies might appear well justified in coming to the conclusion that the 45th President of the United States is set be an economic disaster. But it would be a mistake for investors…
Savers should brace themselves for more pain as the Bank of England’s latest interest rate cut filters through the system and inflation begins to creep higher. The Bank of England cut its base rate in half in August, from 0.5% to 0.25%, and expanded its Quantitative Easing (QE) programme by £60 billion to £435 billion.…
As seen in the latest issue of Master Investor Magazine At 14:46 on Friday 11th March 2011, the Tohuku earthquake – now sometimes referred to as the Great East Japan earthquake – struck off the east coast of Japan. At a magnitude of 9.0 (Mw) it was the most powerful earthquake ever recorded to have…
As featured in this month’s issue of Master Investor Magazine Since the dawn of civilisation humans have been fascinated with the concept of flight. From the legendary flight of Icarus in Ancient Greece and the Renaissance sketches of Leonardo da Vinci, to the Wright Brothers’ first successful manned flight in 1903, we have literally reached…
As seen in the latest issue of Master Investor Magazine “In terms of VR, I don’t think it is a niche.” – Tim Cook, Apple CEO Dawn of a New Age Radio, telephone, television, the Internet: our world has been shaped by intermittent waves of game-changing technology. All of the innovations listed above were once…
An Interview with Ian Walters, MD, CEO of SalvaRx plc James Faulkner: Hi Ian. SalvaRx describes itself as a drug discovery and development company focused on immune-oncology. To the layman such as myself, that’s stimulating the immune system to fight cancer, right? Ian Walters: Yes, some describe immunotherapy as fighting cancer from within. If your…
An Interview with Andrew Newland, CEO of Angle (AIM:AGL) Plc James Faulkner: Hi Andrew. The last time we met Angle had several different projects in development, but now the company is focused solely on commercialising its patented Parsortix liquid biopsy system, which has potential applications in the diagnosis and treatment of certain cancers. Please take us…
Hi Lucius. Thanks for taking the time to speak with Master Investor. Oxford Technology specialises in making and managing investments in start-up and early stage technology-based businesses with high growth prospects. Can you give us a brief introduction to the business and a bit of background info? Oxford Technology Management Ltd (OTM) has specialised in investing…
An interview with Neil Ritson, CEO of Solo Oil Plc James Faulkner: Hi Neil. Thanks for taking the time to speak with Master Investor. Please introduce Solo Oil to our readers and explain why it is different from other Oil & Gas companies? Neil Ritson: It’s a pleasure to share some thoughts about Solo Oil,…
